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Abstract
Radioadaptive response (RAR) describes a phenomenon in a variety of in vitro and in vivo systems that a low-dose of priming
ionizing radiation (IR) reduces detrimental effects of a subsequent challenge IR at higher doses. Among in vivo investigations,
studies using the mouse RAR model (Yonezawa Effect) showed that RAR could significantly extenuate high-dose IR-induced
detrimental effects such as decrease of hematopoietic stem cells and progenitor cells, acute radiation hematopoietic syndrome,
genotoxicity and genomic instability. Meanwhile, it has been demonstrated that diet intervention has a great impact on health, and
dietary restriction shows beneficial effects on numerous diseases in animal models. In this work, by using the mouse RAR model
and mild dietary restriction (MDR), we confirmed that combination of RAR and MDR could more efficiently reduce radio-
genotoxic damage without significant change of the RAR phenotype. These findings suggested that MDR may share some common
pathways with RAR to activate mechanisms consequently resulting in suppression of genotoxicity. As MDR could also increase
resistance to chemotherapy and radiotherapy in normal cells, we propose that combination of MDR, RAR, and other cancer
treatments (i.e., chemotherapy and radiotherapy) represent a potential strategy to increase the treatment efficacy and prevent IR
risk in humans.
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Introduction
Ionizing radiation (IR) is a carcinogen. It is capable of inducing
genotoxicity and genomic instability (GI), in particular, at high
doses. Radiation-induced genotoxicity and GI are characterized
by varied endpoints such as chromosomal rearrangements and
aberrations, micronucleus formation and gene mutation, having
a big impact on radiocarcinogenesis.1,2 GI is central to carci-
nogenesis3 and radiation-induced GI is the driving force
responsible for radiocarcinogenesis.1,4,5 As humans are una-
voidably exposed to IR at higher doses in some circumstances
such as long-term spaceflight mission and radiotherapy, limit-
ing cancer risk from exposure to IR is of great public concern.
A lot of factors could modify IR-induced biological effects
including carcinogenesis, such as pre-exposure to IR at low
doses, and dietary and life-style related factors. Radioadaptive
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response (RAR) manifests as a decrease of radiosensitivity in
which a low-dose of priming IR reduces the detrimental effects
of subsequent challenge IR exposure at a higher dose. As an
evolutionarily conserved phenomenon, RAR has been demon-
strated in a variety of in vitro and in vivo biosystems from
simple prokaryotes to higher eukaryotes including mammalian
animals.6 In vivo investigations showed that RAR could reduce
challenge dose-induced DNA damage, micronucleus forma-
tion, chromosomal aberrations, cell transformation, cell death,
hematopoietic death, and carcinogenesis.6-12 In a series of pre-
vious studies using the RAR mouse model (Yonezawa Effect)
which could rescue bone marrow death through induced resis-
tance in the hematopoietic system,13,14 we confirmed that RAR
could reduce radiation-induced genotoxcity and GI measured
as decreased frequency of micronucleus erythrocytes in bone
marrow cells and reduced frequency of delayed homologous
recombinant cells in bone marrow nucleated cells and spleno-
cytes.15,16 On the other hand, dietary and lifestyle-related fac-
tors could influence health in many species and play key roles
in modulating the risk of developing cancer. As a fact, certain
cancers are primarily dependent on dietary habits.17,18 It has
been known since the early work that dietary restriction, i.e.
calorie restriction of either calories or macronutrients and fast-
ing, would be a potent intervention against development of
cancer including its initiation, progression and metastasis,19 act
synergistically with other treatments,20 and be capable of
decreasing significantly the incidence of both spontaneous and
induced neoplasms in experimental carcinogenesis.19,21-24 For
example, on prevention of radiocarcinogenesis, investigations
showed that food or caloric restriction decreased dramatically
gamma- or X-ray-induced solid tumors and/or leukemias in
mice and rats.25-27 Caloric restriction onset either pre- or
post-exposure to X-rays could extend latency of myeloid leu-
kemia, and prevent radiation-induced myeloid leukemia and
life shortening in mice.28-31 Furthermore, post-exposure onset
of dietary intervention (calorie restriction) in animal models
showed extended lifespan, reduced frequencies of radiocarci-
nogenesis (late-occurring tumor) and mutations.32,33 These
studies demonstrated that dietary restriction could generally
prevent incidence of radiocarcinogenesis, irrespective of cal-
orie restriction onset timing in terms of irradiation, in experi-
mental models.
In this work, for the first time in the research fields of RAR
and dietary intervention, the impact from combination of mild
dietary restriction (MDR) and induction of RAR on high-dose
IR-induced genotoxicity was investigated in a mouse model
measured as micronucleus erythrocytes in the bone marrow.
Materials and Methods
Animals
Three-week-old C57BL/6 J Jms strain female mice, wean just
from breastfeeding, were purchased from SLC, Inc. (Japan). To
avoid possible effects from the developmental condition of the
animals, any mouse with a significantly different body weight
(more or less than the mean + 2 SD) upon arrival was omitted
from this study. The selected mice were randomly assigned to
2 experimental groups either allowed free access to a standard
laboratory chow MB-1 (Funabashi Farm Co., Japan) or under a
MDR. The animals under MDR were given daily (around
9:30 am) 85% of the amount (weight in gram) of the chow
consumed by the animals that were allowed to free access to
the diet. Ingredients of the diet MB-1 contained 24.2% crude
protein, 4.4% crude fat, and 54.4% carbohydrate. The metabo-
lizable energy was 354.0 kcal/100 g. As the mean amount of
chow consumed by per mouse allowed free access to the diet
was 2.92 g per day, each of the mice under MDR was given
daily 2.48 g of the chow. Thus, the weekly metabolizable
energy was 72.36 kcal and 61.45 kcal respectively for each
of the mice with no diet restriction and under diet restriction.
All animals were maintained in a conventional animal facility
under a 12 h light-12 h dark photoperiod, housed in autoclaved
cages (1 mouse per cage) with sterilized wood chips, and
allowed access to acidified water (pH ¼ 3.0 + 0.2) ad libitum.
Animals in each of the experimental groups were further
divided into 3 subgroups, namely, the control group (without
exposure to radiation), the RAR induction group (receiving
both a priming dose and a challenge dose), and the high-dose
exposure group (receiving only a challenge dose). Based on our
previous studies and preliminary trials, in the present study at
least 20 mice were used in each experimental subgroup and the
experiment was repeated once. All experimental protocols
(Experimental Animal Research Plan No. 09-1049 -1) involv-
ing mice were reviewed and approved by The Institutional
Animal Care and Use Committee of the National Institute of
Radiological Sciences, National Institutes for Quantum and
Radiological Science and Technology (QST-NIRS). The
experiments were performed in strict accordance with the
QST-NIRS Guidelines for the Care and Use of Laboratory
Animals.
Irradiation
X-rays were generated with an X-ray machine (Pantak-320 S,
Shimadzu, Japan) operated at 200 kVp and 20 mA, using a 0.50
mm Alþ 0.50 mm Cu filter. An exposure-rate meter (AE-1321
M, Applied Engineering Inc, Japan) with an ionization cham-
ber (C-110, 0.6 ml, JARP, Applied Engineering Inc, Japan) was
used for the dosimetry. The dose rate for delivering the priming
dose and the challenge dose was at about 0.30 Gy/min and 0.90
Gy/min, respectively. The mice held in acryl containers were
exposed to total body irradiation (TBI) at room temperature.
Mouse Model for Induction of Radioadaptive Response
The mouse model for induction of RAR measured as signifi-
cant rescue of bone marrow death (Yonezawa Effect) estab-
lished by Yonezawa and colleagues.13 In this model there were
basically 2 types of combination for the latitude of priming
dose and the interval of irradiation timing (between the priming
dose and the challenge dose). Both types of combination were
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adopted, verified and confirmed in C57BL/6 J Jms female mice
under the experimental conditions in our research facilities.
The type of combination for 0.5 Gy of the priming dose and
2-week interval of irradiation timing was finally applied to the
present work. Namely, the timing for delivery of the priming
dose and challenge dose was on postnatal ages of 6 and 8 weeks
of the mice, respectively. A dose of 0.5 Gy was used as the
priming dose to verify the existence of RAR in the 30-day
survival test and to investigate the incidence of micronucleus
erythrocytes in femur bone marrow. For the challenge dose, a
lethal dose at 7.5 Gy was used in the 30-day survival test and a
non-lethal dose at 4.0 Gy was used in micronucleus test.
Micronucleus Test
The bone marrow micronucleus test was carried out accord-
ingly.15 Induction of micronucleus erythrocytes in bone mar-
row by TBI was used as an index to evaluate both acute
radiogenotoxicity and radiation-induced GI depending on early
and late timing of measurement after exposure. Mice were
sacrificed the following day after the 30-day survival test. Bone
marrow smears prepared from both femurs were processed for
the enumeration of micronucleated polychromatic erythrocytes
(MNPCEs) and micronucleated normochromatic erythrocytes
(MNNCEs). The slides were coded to avoid observer bias. The
micronuclei were scored using a light microscope at a magni-
fication of 1000 . At least 5000 PCEs and 5000 NCEs per
mouse were counted and the data for each experimental point
were from at least 5 mice.
Physiological Endpoints
Physiological conditions were comparatively studied in mice
that were allowed free access to the diet and being under MDR.
The assessments included evaluating changes in body mass and
main organ/tissue weights, and measurements of peripheral
hemogram and bone marrow cellularity (number of nucleated
cells). Body weight gain was monitored weekly from onset of
MDR at postnatal age 4 weeks to the end of experiment at
postnatal age 13 weeks. Main organ and intra-abdominal fat
weights, peripheral hemogram, and femur bone marrow cellu-
larity were measured at the end of the experiment. For analysis
of hemogram, peripheral blood was collected with a hepari-
nized syringe in vacutainer blood collection tubes containing
EDTA (Venoject II, Terumo Co., Japan), then samples were
immediately subjected to a differential blood cell count and
hemoglobin concentration measurement using a blood cell dif-
ferential automatic analyzer (SYSMEX K-4500, Sysmex Cor-
poration, Japan). The data for each experimental subgroup
were from at least 5 mice.
Statistical Analysis
Statistical evaluation of the data was done using the Chi-
squared test for the 30-day survival and micronucleus test, and
Student’s t-test for the other endpoints. The statistical signifi-
cance was assigned to P < 0.05.
Results
Validation of Physiological Effects From Mild Dietary
Restriction
Physiological effects were assessed by evaluating changes in
body mass and main organ/tissue weights, peripheral hemo-
gram, and bone marrow cellularity. Body mass measurements
of animals under MDR pointed to a general significantly lower
body weight gain 1 week after onset of MDR until the end of
the experiment compared to that of animals allowed free access
to the diet (Figure 1A). No significant changes in the weight of
brain, liver, spleen, and kidney except for a markedly decreased
intra-abdominal fat weight were observed in mice being under
MDR (Figure 1B). No changes were observed in peripheral
hemogram measured as cell count and hemoglobin concentra-
tion (Figure 1C) and bone marrow cellularity measured as
number of nucleated cells (Figure 1D). In addition, all mice
being under MDR looked normal and healthy throughout the
whole monitoring period. Results indicated that there is no
significant detrimental physiological effect from MDR on mice
during the whole period of diet regimen in our experimental
setup.
Validation of Radioadaptive Response Induction in Mice
Under Mild Diet Restriction
Reproducibility of the RAR mouse model (Yonezawa Effect)
was verified in mice allowed free assess to the diet (Figure 2A)
and being under MDR (Figure 2B) using 30-day survival test.
For mice allowed free assess to the diet, the survival rate was
16.7% and 80.0% respectively for animals receiving a chal-
lenge dose of 7.5 Gy at postnatal 8 weeks and animals receiving
both a priming dose of 0.5 Gy at postnatal 6 weeks and a
challenge dose of 7.5 Gy at postnatal 8 weeks. For mice being
under MDR, the survival rate was 13.3% and 76.7% respec-
tively for animals receiving a challenge dose of 7.5 Gy and
animals receiving both a priming dose of 0.5 Gy and a challenge
dose of 7.5 Gy. Results demonstrated that the priming dose
could successfully induce a RAR in mice regardless of the diet
regimen. Furthermore, neither marked differences in survival
rate after exposure to the challenge dose alone, nor significant
differences in efficacy for induction of RAR were observed
regardless of the diet regimen. These results clearly demon-
strated that there is no significant modifying effect from MDR
on responses to the high challenge dose alone and induction of
RAR measured as the survival rate in 30-day survival test.
Validation of Micronucleus Incidence in Bone Marrow
Erythrocytes
Incidence of MNPCEs (Figure 3A) and MNNCEs (Figure 3B)
in bone marrow erythrocytes was assessed in mice allowed free
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access to the diet and being under MDR. In general, regardless
of the diet regimen, exposure of animals to the challenge dose
(4.0 Gy) alone induced a markedly increased incidence of
MNPCEs and MNNCEs, and induction of RAR by the priming
dose (0.5 Gy) significantly reduced the incidence of MNPCEs
and MNNCEs caused by the subsequent challenge dose. While
for animals receiving the challenge dose, incidence of
MNPCEs and MNNCEs was respectively 5.5 + 1.1 and
4.0 + 1.2 per mille (‰) in mice that were allowed free access
to the diet. Incidence of MNPCEs and MNNCEs was respec-
tively 3.1 + 1.1 and 3.0 + 1.0 ‰ in mice under MDR. On the
other hand, for animals receiving both the priming dose and the
challenge dose, incidence of MNPCEs and MNNCEs was
respectively 1.8 + 0.5 and 1.8 + 0.5 ‰ in mice that were
allowed free access to the diet. Incidence of MNPCEs and
MNNCEs was respectively 1.0 + 0.3 and 0.9 + 0.4 ‰ in
mice under MDR. Of note, in animals receiving both the prim-
ing dose and the challenge dose, incidences of both MNPCEs
and MNNCEs in mice under MDR were significantly lower
than that in mice that were allowed free access to the diet.
Results clearly demonstrated that induction of RAR could
relieve radiogenotoxicity caused by the high challenge dose,
and increased efficacy for reduction of radiogenotoxicity could
be further achieved in combination with MDR.
Discussions
Increased opportunity for exposure to IR due to such as cancer
radiotherapy and long-term space mission is associated with an
increasing risk of health effects in humans, in particular, carci-
nogenesis. Reducing health risk from unavoidable IR exposure
of normal tissue in medical treatment and spaceflight crew is of
great concern and significance. To modify the radioresistance of
normal tissues and cancer cells whenever possible, triggering
the mechanisms to selectively increase the radioresistance of the
normal tissues and sensitize the cancer cells is of great impor-
tance. Many approaches such as development of radioprotective
agents, pharmaceutical gene regulation, and intervening dietary
Figure 1. Physiological effects from diet restriction on mice. Body weight gain (A), ratio of organ or tissue weight to the body weight (B),
peripheral hemogram (C), and bone marrow cellularity (D) were measured to comparatively study the effect. Body weight (g) is presented as
mean + SD (A). The solid line and dotted line stand for mice having free access to the diet and being under diet restriction, respectively. The
ratio of organ or tissue weight (g) to the body weight (g) measured at postnatal age 13 weeks is presented as mean + SD (B). The open bar,
striped bar, dotted bar, transversely striated bar, and solid bar stand for brain, liver, spleen, kidney, and intra-abdominal fat, respectively.
Peripheral hemogram was measured at postnatal age 13 weeks (C). Cell count or hemoglobin concentration is presented as mean + SD. The
solid bar, open bar, dotted bar and striped bar stands for white blood cell count (WBC), red blood cell count (RBC), hemoglobin concentration
(HGB), and blood platelet count (PLT), respectively. Bone marrow cellularity was measured as total cell count of nucleated cells in 2 femurs per
mouse (D). One (*) and 2 asterisks (**) respectively indicate statistically significant differences at P < 0.05 and P < 0.01 between the 2 groups that
were compared.
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habit, psychological stress and life style were proposed.34 When
compared to the research and development of these therapeutic
modalities, intervention of life-style factors is less time-
consuming and with a low cost, which neither depends on the
advancement of technology. Notably, dietary restriction, as one
of the mostly used intervention of life-style factors, showed a
great promise as a modifier to prevent incidence of radiation-
induced myeloid leukemia in mice, irrespective of calorie
restriction onset timing in terms of irradiation.28-31 It is rational
that initiatives to reduce the health risk from IR exposure should
focus on the tenets of appropriate combination of different
approaches. To date, there is no study on the efficacy of com-
bination of induction of RAR and dietary restriction for reduc-
tion of radiogenotoxicity and IR-induced GI.
The mouse RAR model (Yonezawa Effect) is a well-
designed system in investigating the late health effect in vivo
such as IR-induced GI. In a series of our previous
investigations, we demonstrated that induction of RAR could
relieve IR-induced GI measured as micronucleus formation and
delayed homologous recombination in the hematopoietic sys-
tem.15,16 Recently, we also verified the modifying effects from
dietary factors on the biological response to IR exposure of
mice. Our studies confirmed that there existed an interaction
between life-style factors (i.e., high fat diet, low fat diet and
alcohol drinking) and IR, which could lead to altered responses
to IR in mice.35-37 In the present work, combination of MDR
and RAR was further verified in the mouse RAR model.
Results indicated that MDR would not influence the phenotype
of RAR measured as 30-day survival, and combined treatment
with MDR and RAR could achieve a higher efficacy to relieve
radiogenotoxicity and radiation-induced GI measured as
reduced micronucleus frequency in the erythrocytes in the bone
marrow.
It is known that normal cells and tumor cells from both mice
and humans respond differently to induction of RAR. For
example, in normal cells RAR could be induced measured as
increased cell survival and decreased micronucleus frequency
in the cultured cells in vitro, and increased cell proliferation
and reduced apoptosis in vivo. On the other hand, higher induc-
tion of apoptosis along with high expression of pro-apoptotic
gene Bax and lower expression of anti-apoptotic gene Bcl-2
was induced in tumor cells in tumor-bearing mice under RAR
induction condition.38-40 These works demonstrated clearly
that RAR could be induced in normal cells but not in tumor
cells under both in vitro and in vivo conditions. Interestingly,
diet intervention also has the potential to differently change the
response of normal tissue and tumors, namely, to alleviate
genotoxicity of normal tissue and enhance cytotoxicity of can-
cer cells. Thus, it is expected that innovative use of diet inter-
vention as a novel therapeutic option would bring an additional
clinical benefit in the treatment of cancer patients. These stud-
ies suggested a very important clinic-relevant phenomenon and
implied the potential for application of RAR to protect normal
tissues without diminishing the efficacy of tumor radiother-
apy.40 Collectively, both induction of RAR and appropriate
dietary restriction could selectively protect normal cells from
the side effects of IR at higher doses and sensitize cancer cells
to IR. In this regards, clinically combined application of pro-
phylactic MDR and RAR before cancer radiotherapy would
have a great potential for benefiting cancer patients from the
point of view of increasing the maximum tolerated dose and
reducing the risk of secondary cancer.
It should be pointed out that appropriate dietary restriction
without malnutrition is critical for induction of beneficial
health effects. For examples, moderate food restriction could
suppress aging rate.41 MDR in the present work could enhance
the efficacy of RAR-induced radiogenotoxicity, and in addi-
tion, with a concomitant decrease in body weight gain and
intra-peritoneal fat weight in mice. Conversely, severe dietary
restriction or malnutrition due to unbalanced diet could
increase sensitivity of normal tissues to radiogenotoxicity,
radiation-induced bone marrow death and life shortening in
mice.36,42
Figure 2. Induction of RAR in mice having free access to the diet and
being under diet restriction. Induction of RAR (Yonezawa Effect) by a
priming dose of 0.5 Gy X-rays at postnatal 6 weeks followed by a
subsequent challenge dose of 7.5 Gy X-rays at postnatal 8 weeks was
verified in mice having free access to the diet (A) and being under diet
restriction (B). The solid line, broken line, and dotted line stand for the
mice receiving no TBI (control), the mice receiving the challenge dose
alone (7.5 Gy), and mice receiving both the priming dose and the
challenge dose (0.5 Gy þ 7.5 Gy), respectively. Two asterisks (**)
indicate statistically significant differences (P < 0.01) between the
2 groups that were compared.
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A complete understanding of the underlying mechanisms is
imperative in reducing health risk due to IR exposure in humans.
Protection against radiocarcinogenesis could be achieved by dif-
ferent mechanisms (i.e., free radical scavenging, caloric restric-
tion, anti-inflammation, and humoral factors), and the efficacy
could be enhanced by targeting multiple mechanisms at the same
time.43 For dietary intervention in the animal models, it is firmly
established that the effect depends on many variables, such as
diet composition, feeding regimen, age of onset and genetics, in
addition to the calories provided in the diet.44 For caloric restric-
tion, the anticancer and genomic effects could be established
more rapidly in mitotic tissues. Acute caloric restriction showed
reduced detrimental effects and aging alterations in the organs in
both animal models and in humans, as possibly the highly con-
served mechanisms for health enhancement.45,46
MDR may share some common pathways with RAR to acti-
vate mechanisms consequently resulting in suppression of
genotoxicity. IR could cause both acute tissue damage and late
effects including long-term or residual bone marrow injury. As a
carcinogen, IR poses a significant cancer risk in part by induction
of GI, for example, development of leukemia in hematopoietic
system. Exposure of mice to a sublethal dose of TBI could induce
a persistent increase in ROS production in hematopoietic stem
cells. Studies showed that increased the generation and accumula-
tion of mitochondrial ROS was via overexpression of miR-22 or
nicotinamide adenine dinucleotide phosphate oxidase and led to
induction of hematopoietic GI.47,48 Exposure of mice to TBI could
induce persistent oxidative stress in hematopoietic stem cells at
least in part via up-regulation of nicotinamide adenine dinucleo-
tide phosphate oxidase and associated with sustained increases in
oxidative DNA damage, DNA double-strand breaks, and inhibi-
tion of clonogenic function.47,49 On the other hand, a majority of
studies in animal models and humans showed that dietary
restriction-induced reduced mutations and radiocarcinogenesis are
underlying mechanisms of increased antioxidant glutathione level,
improved redox state, decreased mitochondrial ROS production,
reduced oxidative stress and damage, and decreased chronic
inflammation, leading to an overall reduction of steady-state oxi-
dative damage to macromolecules including proteins, lipids and
DNA in animals.23,32,33,50-54 Meanwhile, RAR is also known as
through mechanisms of increased antioxidant capability,
decreased ROS production, reduced oxidative stress and damage,
increased DNA repair and decreased chronic inflammation.7-12
As diet and metabolism link to cancer, for cancer treatment,
it was demonstrated that dietary restriction could simultaneously
target many signal pathways that were targeted by anticancer
drugs20 and cancer radiotherapy. For example, in mouse model,
investigation showed that calorie restriction could augment effi-
cacy of radiotherapy in breast cancer.55 In humans, study showed
that caloric restriction coupled with radiotherapy could decrease
metastatic burden in triple negative breast cancer.56 These studies
indicated that diet intervention could be used in conjunction with
chemotherapy and radiotherapy to render cancer cells more sus-
ceptible to treatment, which could lead to new cancer therapies
using the metabolism-involved mechanisms. Dietary restriction
could increase DNA repair in mice.57 Equally interesting and
important, increasing convincing evidence in animal models
showed that post-exposure onset of calorie restriction could also
reduce frequencies of radiocarcinogenesis. Pre-exposure caloric
restriction could prevent the initiation of direct genotoxic leuke-
mogenesis, and post-exposure could improve mitochondrial
function, reduce production of reactive oxygen species, and
relieve indirect and epigenetic leukemogenesis.28-33,58
In summary, the present work demonstrated that combined
treatment with RAR and MDR could more efficiently relieve
high-dose IR-induced genotoxicity in mice. These findings
indicated that diet intervention could be a potential modifiable
factor for reducing risk from IR exposure and provide a clear
direction for initiating such studies prior to clinical implemen-
tation in humans. As a potentially promising strategy for reduc-
ing long-term IR health risk from cancer radiotherapy,
combination of RAR induction and lifestyle management
(i.e., MDR) could maximize medical utilization of IR, via
Figure 3. Incidence of MNPCEs and MNNCEs induced by TBI in femur
bone marrow erythrocytes (RBC) in mice having free access to the diet
and being under diet restriction. Incidence as the number of MNPCEs
per 1000 PCEs (A) or of MNNCEs per 1000 NCEs (B) is presented as
mean + SD. The open bar, solid bar, and striped bar stand for samples
from mice receiving no TBI (control), the mice receiving a challenge
dose alone (4.0 Gy), and mice receiving both a priming dose and a
challenge dose (0.5 Gy þ 4.0 Gy), respectively. One (*) and 2 asterisks
(**) respectively indicate statistically significant differences at P < 0.05
and P < 0.01 between the 2 groups that were compared.
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increasing the organ tolerance dose and reducing radiogeno-
toxicity, radiation-induced GI and radiocarcinogenesis.
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